GHAZEL WAIZ: Open Payments
NPI 1265015077 · FAIRFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 11 payments from 5 companies in 2025. Trend: 2023 $868 · 2024 $648 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $193 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| ABBVIE INC. | 1 | $130 |
| Incyte Corporation | 2 | $44 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
Products named: VTAMA, DUPIXENT, OPZELURA, Zoryve.
Industry payments across CA — which companies pay providers there.
